CEOs from Medtronic, Intuitive Surgical, Boston Scientific and Dexcom were on hand this week in San Francisco to discuss the year ahead at the J.P. Morgan Healthcare Conference.
The new director of the FDA’s device center contrasted a European rule with the U.S.’s lack of mandatory reporting requirements for potential device shortages.
BD invested $10 million last year to increase manufacturing capacity. The recent expansion has created more than 200 jobs.
Gary Guthart gave a glimpse of surgeons’ initial response to the new robot at the J.P. Morgan Healthcare Conference.
Hologic stopped manufacturing the device after reports of serious adverse events in patients who had the markers implanted in ...
A report found China limits EU-based device manufacturers’ access to its market through policies that favor local suppliers ...
FetalEase is a privately held Israeli start-up company dedicated to commercializing the Yaari Extractor, a simple mechanical device that resolves shoulder dystocia, an obstetric emergency in which the ...
Kevin Sayer said at the J.P. Morgan Healthcare Conference that Dexcom also expects to release a 15-day glucose sensor in the second half of the year.
Massimiliano Colella joined the robot maker as chief commercial officer in 2023 and stepped into the top job when former CEO ...
Hologic stopped manufacturing the device after reports of serious adverse events in patients who had the markers implanted in breast tissue.
New technologies for atrial fibrillation, hypertension, diabetes and neurological conditions are poised for fast growth, ...
Some electrocardiogram events, such as atrial fibrillation or abnormally rapid heartbeats, over two years were not reviewed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback